SCHEMBL1760746

SCHEMBL1760746

CCN1C(=O)c2cccc3c(NCCCCC[n+]4ccn(CCCNc5ccc6c7c(cccc57)C(=O)N(CC)C6=O)c4)ccc(c23)C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.55
MAPT P10636 3/20 0.55
HTT P42858 3/20 0.55
MEN1 O00255 2/20 0.55
USP2 O75604 2/20 0.55
ATM Q13315 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
RGS12 O14924 1/20 0.55
POLB P06746 1/20 0.55
MAPK1 P28482 1/20 0.55
TLR9 Q9NR96 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
DYRK3 O43781 1/20 0.49
RPS6KB1 P23443 1/20 0.49
EPHA2 P29317 1/20 0.49
FLT4 P35916 1/20 0.49
CSNK2A1 P68400 1/20 0.49
HDAC1 Q13547 3/20 0.47
HDAC6 Q9UBN7 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14397348 0.98 KMT2A (0.55) KMT2AMAPTHTTMEN1USP2
SCHEMBL20080445 0.96 KMT2A (0.56) KMT2AMAPTHTTMEN1USP2
SCHEMBL1760764 0.94 KMT2A (0.54) KMT2AMAPTHTTMEN1USP2
SCHEMBL1760767 0.92 KMT2A (0.54) KMT2AMAPTHTTMEN1USP2
SCHEMBL1760787 0.90 MEN1 (0.55) KMT2AMAPTHTTMEN1USP2
SCHEMBL1760760 0.88 MEN1 (0.55) KMT2AMAPTHTTMEN1USP2
SCHEMBL1760751 0.86 MEN1 (0.55) KMT2AMAPTHTTMEN1USP2
SCHEMBL13207584 0.86 MEN1 (0.47) KMT2AMAPTHTTMEN1USP2
SCHEMBL1760808 0.86 MEN1 (0.52) KMT2AMAPTHTTMEN1USP2
SCHEMBL1760739 0.85 MEN1 (0.51) KMT2AMAPTHTTMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7988741-B2 Specific naphthalmide-type dyes, dye composition comprising at least one such dye, process using same and uses L'OREAL S.A. (FR) 2011-08-02 US claimed
US-20110113572-A1 SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES L' OREAL S.A. (FR) 2011-05-19 US claimed
EP-1963436-A2 SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES L'Oréal (FR) 2008-09-03 EP claimed
WO-2007110530-A2 SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES L'OREAL (FR) 2007-10-04 WO claimed
US-7988741-B2 Specific naphthalmide-type dyes, dye composition comprising at least one such dye, process using same and uses L'OREAL S.A. (FR) 2011-08-02 US disclosed
US-20110113572-A1 SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES L' OREAL S.A. (FR) 2011-05-19 US disclosed
US-20110113572-A1 SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES L' OREAL S.A. (FR) 2011-05-19 US disclosed
EP-1963436-A2 SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES L'Oréal (FR) 2008-09-03 EP disclosed
WO-2007110530-A2 SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES L'OREAL (FR) 2007-10-04 WO disclosed
WO-2007110530-A2 SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES L'OREAL (FR) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110113572-A1 SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES KRT18, NEFM, NDC1 KMT2A 2748/4885MAPT 461/4885HTT 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.